Symptom management and quality of life in metastatic breast cancer

Meeting the needs of the elderly, unfit CLL patient

Drop in breast cancer mortality in developed countries varies

Translational studies of CDK and PARP inhibitors

HER2 positive breast cancer treatment, past and future

Moving breast cancer stem cell therapies to the clinic

PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Where to next for the elderly with acute myeloid leukaemia?

Long term use of aromatase inhibitors and compliance

New line of therapy for acute myeloid leukaemia

Novel agent CC-292 for CLL using the B-cell receptor pathway